Management of a Multidrug-Resistant Pseu
โ
Panayiotis J. Papagelopoulos; Andreas F. Mavrogenis; Efthymia Giannitsioti; Atha
๐
Article
๐
2007
๐
Elsevier Science
๐
English
โ 196 KB
Multidrug-resistant infections present a serious clinical and therapeutical problem. Colistin is an old-used polymyxin with rather poor pharmacokinetic profile and a remarkable nephrotoxicity. However, the emergence of multidrug-resistant bacteria has recently led to the increased use of colistin as